Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe
|
|
- Camron Greene
- 5 years ago
- Views:
Transcription
1 No conflict of interest Recent developments in the detection of harms arising from the use of synthetic cathinonesin Europe Ana Gallegos 24 September 2015 Lisbon Addictions Conference 2015 Paper session 10 New opportunities for harm reduction: behaviours
2 The EU Early Warning System on NPS since 1997 Reporting - forensic analysis Targeted research Open source information
3 The EU Early Warning System on NPS Total: 527 substances under monitoring; 60% of which since synthetic cathinones monitored by the EWS 31 new in 2014; 18 new in methylone
4 The EU Early Warning System on NPS Internationally controlled, 2015 * Reviewed 36 th /37 th ECDD meetings Under the terms of the Joint Action 97/396/JHA > 30 new synthetic drugs detected 9 risk assessments 6 substances controlled Under the terms of the Council Decision 2005/387/JHA 2005 present > 450 new psychoactive substances detected 10 risk assessments 8 substances controlled MTA PMMA * 2005 Mephedrone 5-IT α-pvp * MBDB Ketamine * GHB 2C-I 2C-T-2 2C-T-7 TMA-2 BZP 4-MA Methoxetamine * MDPV 25I-NBOMe AH ,4 -DMAR * MT-45 * 4
5 NPS phenomenon Consistent increase in Substances notified Seizures (number and weight) Serious adverse events associated with NPS 5
6 Number of seizures of synthetic cathinones(nsz) NSz and quantity seized (powders), NSz and proportion of seizures by substance, seizures amounting to more than 1.1 tonnes in 2013
7 Number of seizures of synthetic cathinones(nsz) NSz and quantity seized (powders), NSz and proportion of seizures by substance, 2013 Many of them are used as replacements for stimulants. Typically supplied as a powder; but also in tablet, capsule and liquid form. They are soluble in water and the powder can be dissolved for oral use or intravenous and subcutaneous injection.
8 Number of seizures by substance NSz and proportion of seizures by substance, Mephedrone RA MDPV α-pvp
9 Chemistry Cathinone Amphetamine Methcathinone Khat Catha edulis Forsk 9
10 Structural diversity 10
11 Chemical structure sufficiently different so they fall outside the cope of (inter)national drug laws Internationally controlled 1971 UN Convention Cathinone Pyrovalerone Methcathinone Schedule I Schedule IV Schedule I alpha-pyrrolidinovalerophenone α PVP 3,4-methylenedioxypyrovalerone MDPV 4-methylmethcathinone 4-MMC, mephedrone EU joint report, 2015 Under review (2015) EU risk assessment, 2014 Schedule II (2015) EU risk assessment, 2010 Schedule II (2015) 11
12 Pharmacology considerable diversity of pharmacology within the group of cathinones Cathinone Methamphetamine-like cathinones Methcathinone Schedule I Schedule I Toxicity similar to amphetamine, including: hypertension, hyperthermia, euphoria, locomotor activation, and hallucinations following higher or repeated doses. Liechti, M.E. Swiss Med Wkly. 2015;145:w14043
13 Pharmacology considerable diversity of pharmacology within the group of cathinones Cocaine/MDMA cathinones 4-methylmethcathinone 4-MMC, mephedrone EU risk assessment, 2010 Schedule II (2015) Empathogen/stimulant-type effects; dependence potential Subjective effects similar to those of cocaine but also MDMA It has been reported to produce strong craving in humans and to be more addictive than cocaine. Acute toxicity: sympathomimetic toxidrome, agitation, vomiting, psychosis, chest pain, seizures, insomnia Liechti, M.E. Swiss Med Wkly. 2015;145:w
14 Pharmacology considerable diversity of pharmacology within the group of cathinones alpha-pyrrolidinovalerophenone α PVP Pyrovalerone-like cathinones Pyrovalerone 3,4-methylenedioxypyrovalerone MDPV EU risk assessment, 2014 EU joint report, 2015 Schedule IV Schedule II (2015) More potent than cocaine or methamphetamine High lipophilicity they cross readily the blood-brain barrier Risks of sympathomimetic toxicity and of addiction in humans Acute toxicity: sympathomimetic toxidrome, agitation, psychosis, hallucinations, combative behaviour, chest pain, prolonged insomnia Liechti, M.E. Swiss Med Wkly. 2015;145:w
15 Mephedrone 4-methylmethcathinone Finland 1 st occurrence Finland 1 st notification first cases of acute toxicity reported European risk assessment Decision of control at European level Australia 4 capsules submitted to hospital (Neorganics) UK 1 st notification Media hype 2010 UK first toxicologically confirmed fatalities and large seizures 2015 International control Sc II UN Convention controlled under the UK Misuse of Drugs Act
16 Sample of mephedrone bought in Lisbon (2010) 16
17 MDPV MDPV has potent cocaine-like stimulant properties. MDPV was reported in seizures in 27 MS, Norway and Turkey. In excess of seizures were reported, with two countries reporting >1000 seizures each (UK, FI). The total amount of powder seized was over 200 kg. EMCDDA monitoring of Internet suppliers and retailers selling MDPV identified more than 20 companies that may be based within the European Union and China, offering up to multi-kilogram quantities of the substance. A total of 525 non-fatal intoxications associated with MDPV have been reported by 8 MS. Key adverse effects associated with MDPV intoxication frequently reported in clinical case reports include: paranoid psychosis, hypertension, tachycardia, diaphoresis, severe agitation, auditory and visual hallucinations, profound anxiety, hyperthermia, violent outbursts and multiple organ dysfunction. There have been a total of 108 deaths associated with MDPV reported by 8 MS and Norway in which MDPV has been detected in biological samples.
18 α-pvp α-pvp, similarly to MDPV, is a potent psychostimulant with abuse liability and dependence potential. α-pvp has been available in the EU since at least February 2011 and has been detected in 28 MS, Turkey and Norway. In excess of 5200 seizures were reported with 8 countries reporting > 100 seizures each (UK, FI, SK, SE, IE, HU & TK). The total amount of powder seized was over 750 kg. It has been seized as a powder, but other forms including tablets have been detected. Multi-kilogram quantities of α-pvp have been seized at EU borders which usually originate from China. This includes the seizure of more than 280 kg in Illicit production and tableting sites have also been seized. α-pvp is sold as a research chemical online and is available in wholesale and consumer amounts. 140 serious adverse events associated with α-pvp have been reported by 9 MS. This includes acute intoxications requiring hospitalisation and more than 100 deaths; in at least 23 of these deaths α-pvp was the cause of death or contributed to it. 18
19 Conclusions Synthetic cathinones have carved a space in the illicit stimulants market. The injection of synthetic cathinones by high risk drug users has been reported in a number of countries in Europe. Injecting cathinones carries public health risks of bacterial infections and transmission of blood-borne viruses such as human immunodeficiency virus, hepatitis C virus and hepatitis B virus. Data suggests that injection of these substances lead to different treatment needs than illicit drugs (more frequent injecting, sharing of injecting equipment and psychosis). Research needed (pharmacological & toxicological studies). 19
20 Thank you emcdda.europa.eu twitter.com/emcdda facebook.com/emcdda youtube.com/emcddatube flickr.com/photos/emcdda
The EU Early Warning System: 20 years of monitoring New Psychoactive Substances in Europe
The EU Early Warning System: 20 years of monitoring New Psychoactive Substances in Europe Rachel Christie, PhD NDEWS webinar: Examining Global Drug Early Warning Systems, Part 4: Monitoring Drug Trends
More informationThe Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015
The Challenge of New Psychoactive Substances (NPS) A Presentation for CAD by Dr Des Corrigan October 2015 New Psychoactive Substances Any substance, natural or synthetic which can produce stimulation or
More informationThe issues facing Europe
The issues facing Europe An overview Andrew Cunningham Supply reduction and New Drugs unit 28 May 2015 European Drug Report 2015 https://youtu.be/vzzyp3k6psk 2 Opiates (heroin) Europe s main drug issue
More informationSubstances under Surveillance
Substances under Surveillance The following substances are under surveillance by the World Health Organization (WHO) as they are considered to have the potential to cause public health harm. For ease of
More informationEWS manual information flow alert database on NPS
EWS manual information flow alert database on NPS 2nd Annual meeting COPOLAD II: National drugs observatories Lisbon, 13-17 November 2017 Flow of information Principal objective of EWS collect and disseminate
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
1 INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-SECOND REGULAR SESSION November 28-30, 2012 San José, Costa Rica OEA/Ser.L/XIV.2.52 CICAD/doc.1988/12
More informationNPS use, harms and health responses to NPS in Europe: findings form multi-method studies
NPS use, harms and health responses to NPS in Europe: findings form multi-method studies Alessandro Pirona Brussels, September 2017 NPS & public health responses Set the scene by providing a brief update
More informationEMCDDA-update HIV/HCV among people who inject drugs: situation and response
EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis
More informationObjectives. Why new drugs? New drugs of abuse: synthetic cannabinoids, stimulants, and 10/14/2015. Describe several new drugs of abuse
New drugs of abuse: synthetic cannabinoids, stimulants, and more Robert G. Hendrickson, MD Professor, Emergency Medicine, OHSU Program Director, Medical Toxicology Fellowship Associate Medical Director,
More informationRisk Assessment of Psychoactive Substances: Potentialities and Limitations
Risk Assessment of Psychoactive Substances: Potentialities and Limitations Leslie A. King, MSc, PhD ReDUse Conference, Vienna, 16 November 2012 1 Overview Why and how risk assessments on psychoactive substances
More informationProposal for a COUNCIL DECISION
EUROPEAN COMMISSION Brussels, 1.12.2014 COM(2014) 716 final 2014/0340 (NLE) Proposal for a COUNCIL DECISION on subjecting 4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4'-DMAR) and 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine
More informationAnnual report 2012: the state of the drugs problem in Europe
Annual report 2012: the state of the drugs problem in Europe Ilze Jekabsone, MD, MPH Reitox and international cooperation unit 14 December 2012 2 Setting the scene After 30+ years with heroin centre stage
More informationMDPV RISK ASSESSMENTS 14. About this series
RISK ASSESSMENTS 14 MDPV ISSN 1725-4493 Report on the risk assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl) pentan-1-one (3,4-methylenedioxypyrovalerone, MDPV) in the framework of the Council
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2106/14
More informationE/CN.7/2015/CRP.10 * * 9 December English only V (E) * The present document is reproduced in the form in which it was received.
9 December 2015 English only Commission on Narcotic Drugs Reconvened fifty-eighth session Vienna, 9-11 December 2015 Agenda item 6 Implementation of the international drug control treaties: Changes in
More informationConventional and emerging drugs of abuse: the current situation
Conventional and emerging drugs of abuse: the current situation NEW PSYCHOACTIVE SUBSTANCES -THE HIGHS AND LOWS Maritim Hotel, Munich, 12-13 November 2015 Michael Uhl Director of Chemistry Unit Bavarian
More informationWhat is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration
What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,
More informationAnnual report 2009: the state of the drugs problem in Europe
Annual report 2009: the state of the drugs problem in Europe Alessandro Pirona, Rome 05/11/2009 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Established: 1993 Seat: Lisbon Staff: 100
More informationFentanils in Europe: perspective from the EU EWS
Fentanils in Europe: perspective from the EU EWS Rita Jorge Lisboa, 19 September 2017 DRD Expert Meeting This presentation The EU EWS The fentanils family Emergence of fentanils in the EU Outbreaks Public
More informationNPS New Psychoactive Substances
NPS New Psychoactive Substances NPS are drugs that are synthetically designed to replicate the effects of illegal substances. People may refer to these drugs as legal highs, but many of the substances
More informationProposal for a COUNCIL IMPLEMENTING DECISION
EUROPEAN COMMISSION Brussels, 18.12.2017 COM(2017) 765 final 2017/0345 (NLE) Proposal for a COUNCIL IMPLEMENTING DECISION on subjecting the new psychoactive substance methyl 1-(2-phenylethyl)-4- [phenyl(propanoyl)amino]piperidine-4-carboxylate
More informationThe European Early-warning system on new drugs. Dr. R. Sedefov & D. Lopez, Ancona, 18 September 2009
The European Early-warning system on new drugs Dr. R. Sedefov & D. Lopez, Ancona, 18 September 2009 This presentation A brief introduction to the EMCDDA and EWS What have we learned? The concept of new
More information9668/15 JV/PN/np 1 DGD2C
Council of the European Union Brussels, 9 June 2015 (OR. en) Interinstitutional File: 2014/0183 (NLE) 9668/15 CORDROGUE 42 NOTE From: To: Presidency Delegations No. Cion doc.: 16240/14 Subject: Draft Council
More informationLisa Booze, PharmD, CSPI
Lisa Booze, PharmD, CSPI Psychoactive drugs created to avoid existing laws Modify existing drugs or new drugs with different chemical structures >200 new drugs and 8 classes of drugs since 2009 80 new
More informationCrime and Justice. New Psychoactive Substances Evidence Review
Crime and Justice New Psychoactive Substances Evidence Review NEW PSYCHOACTIVE SUBSTANCES EVIDENCE REVIEW Fiona Fraser, Safer Communities Analytical Unit, Scottish Government Scottish Government Social
More informationClinical Toxicology: An Update
Clinical Toxicology: An Update Dr. Shaun Greene VICTORIAN POISONS INFORMATION CENTRE AND AUSTIN HOSPITAL CLINICAL TOXICOLOGY SERVICE Drug Abuse in Australasia VICTORIAN POISONS INFORMATION CENTRE AND AUSTIN
More informationfactsheet New psychoactive substances: Who is this factsheet for? Why don t we call them legal highs? What are new psychoactive substances?
New psychoactive substances: factsheet Who is this factsheet for? This factsheet is aimed at professionals who do not work specifically in the drugs field, but who may encounter substance misuse as part
More information2014 Key Australian findings: psychostimulant drug market
214 Key Australian findings: psychostimulant drug market Natasha Sindicich & Lucy Burns National Drug Trends Conference Maritime museum, Sydney Monday, 2 th October, 214 Funded by the Australian Government
More informationSubstance briefing: MDPPP
Substance briefing: MDPPP This technical folder provides information on MDPPP. The information provided is based on a number of existing data sources and work undertaken as part of the I-TREND project.
More informationNew drugs: the European context. Michael Evans-Brown GPS annual expert meeting, June , Lisbon
New drugs: the European context Michael Evans-Brown GPS annual expert meeting, June 19 2013, Lisbon t are new drugs? w drugs usually mimic the effects of controlled drugs. e are sold as having novel psychoactive
More informationProfessor Paul I Dargan
General Overview of the Euro-DEN Dataset: 5529 presentations with acute drug toxicity in 16 sentinel European centres Professor Paul I Dargan Guy s s and St Thomas NHS Foundation Trust and King s s College
More informationEMCDDA Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA
EMCDDA Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA In accordance with Article 10 of Council Decision 2005/387/JHA on the information exchange, risk-assessment and
More informationFlakka : The Truth Behind the Latest Designer Drug Media Storm. Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs
Flakka : The Truth Behind the Latest Designer Drug Media Storm Donna Papsun, MS, D-ABFT-FT Forensic Toxicologist, NMS Labs Flakka Flakka Headlines What is Flakka? Flakka = Spanish slang for thin, pretty
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-EIGHTH REGULAR SESSION November 11-13, 2015 Trujillo, Perú OEA/Ser.L/XIV.2.58 CICAD/doc.2207/15 6
More informationKey findings for drug use patterns & drug markets
EDRS participants & Recruitment Key findings for drug use patterns & drug markets Risk behaviours Help seeking Implications 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Number of EDRS participants
More informationEcstasy and Related Drugs Reporting System: 2016 Findings
Ecstasy and Related Drugs Reporting System: 16 Findings EMCDDA Lisbon Sept 19 th - th Courtney Breen and Amanda Roxburgh on behalf of the Drug Trends Team Drug Trends aims: Document the price, purity,
More informationFiona Coope (BSc) Forensics Director
Fiona Coope (BSc) Forensics Director Who We Are ESG is the UK s leading provider of testing, inspection and compliance services, with comprehensive solutions in Infrastructure, the Built Environment and
More informationAcute Drug Toxicity Data
Acute Drug Toxicity Data Recreational drug use is common Systematic data is available on: Prevalence of drug use Drug seizures Use of treatment agencies for problem drug use Drug-related fatalities There
More informationChanging patterns of new and emerging psychoactive substances in Australia
Changing patterns of new and emerging psychoactive substances in Australia Prepared by Rachel Sutherland, on behalf of the Drug Trends team The Drug Trends program is supported by funding from the Australian
More informationNavy Drug Screening Laboratory Jacksonville Screening News
Navy Drug Screening Laboratory Jacksonville Screening News January 2014 Volume 5, Number 2 In This Issue CO s Desk In Focus Discrepancy of the Month Drug Facts Ask the Expert Contact Us NDSL Jacksonville
More informationHIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015
HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term
More informationA handful of dangerous new legal drugs has public health experts worried
Page 1 of 8 A handful of dangerous new legal drugs has public health experts worried MATTHEW SPEISER AUG. 11, 2015, 5:00 PM Over the past 20 years, the drug world has seen the rise of new psychoactive
More informationAnthony Dekker, DO Chief, Addiction Medicine, FBCH, DoD Clinical Professor, George Washington University and ATSU
Anthony Dekker, DO Chief, Addiction Medicine, FBCH, DoD Clinical Professor, George Washington University and ATSU Anthony.dekker.civ@health.mil Disclosure Anthony Dekker, DO has presented numerous programs
More informationLima - Peru, August 18-22, 2014
2014 GLOBAL SYNTHETIC DRUGS ASSESSMENT Amphetamine-type stimulants and new psychoactive substances Lima - Peru, August 18-22, 2014 Juan Carlos Araneda Ferrer Project Coordinator Global SMART Programme
More informationFactsheet - Mephedrone
Factsheet - Mephedrone Mostly Known As Mephedrone Otherwise Known As Meph Drone Meow MMCAT Magic (mephedrone) Plant Food (mephedrone) 4MMC MCAT Miaow Meow meow 4-methylmethcathinone Bubbles (mephedrone)
More informationInternational Regulatory Environment for the Abuse Liability Evaluation
International Regulatory Environment for the Abuse Liability Evaluation Conference on Preclinical Abuse Liability Testing, October 19-20, 2006, Annapolis MD. Willem Scholten PharmD, MPA Quality Assurance
More informationFACT SHEET. A selection of internet-based information. Methedrone (bk-pmma)
FACT SHEET A selection of internet-based information Methedrone (bk-pmma) Scientific Institute of Public Health Drugs and Illegal Substances Program National Focal Point on Drugs Juliette Wytsmanstreet
More informationEMCDDA Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA
EMCDDA Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA In accordance with Article 10 of Council Decision 2005/387/JHA on the information exchange, risk-assessment and
More informationEMCDDA Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA
EMCDDA Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA In accordance with Article 10 of Council Decision 2005/387/JHA on the information exchange, risk-assessment and
More informationCzech web shop analysis found no web shop advertised branded products as containing 4-MEC substance.
Substance briefing: 4-MEC This technical folder provides information on 4-MEC. The information provided is based on a number of existing data sources and work undertaken as part of the I-TREND project.
More informationBath salts amphetamine for sale
Bath salts amphetamine for sale amphetamine for sale - Find the lowest. Amphetamine such as the salt racemicamphetamine sulfate racemic- amphetamine from a submissive brecht service. 2-12-2010 Synthetic
More informationDesigner Drugs: New ways of achieving old highs
Designer Drugs: New ways of achieving old highs Jen Stephani, MD Oregon Poison Center/OHSU PeaceHealth Southwest WA Medical Center Department of Emergency Medicine Objectives Discuss social & legal evolution
More informationCzech web shop analysis found no web shop advertised branded products as containing 3-mmc substance
Substance briefing: 3-MMC This technical folder provides information on 3-MMC. The information provided is based on a number of existing data sources and work undertaken as part of the I-TREND project.
More informationEWS in the Czech Republic country example
EWS in the Czech Republic country example 2nd Annual meeting COPOLAD II: National drugs observatories Lisbon, 13-17 November 2017 EWS in CZ 1 EWS in the CZ Initiated in 2002, operational since 2003 (establishment
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2089/14
More informationCOUNCIL OF THE EUROPEAN UNION. Brussels, 3 December /01 CORDROGUE 63
COUNCIL OF THE EUROPEAN UNION Brussels, 3 December 2001 13488/01 CORDROGUE 63 NOTE from : to : Subject : European Monitoring Centre for Drugs and Drug Addiction Council and Commission Report on the Risk
More informationSituation Report. National Drug Intelligence Center. Synthetic Cathinones (Bath Salts): An Emerging Domestic Threat. U.S. Department of Justice
U.S. Department of Justice Situation Report July 2011 Product Number 2011-S0787-004 Synthetic Cathinones (Bath Salts): An Emerging Domestic Threat Cox Broadcasting. Executive Summary The (NDIC) assesses
More informationImproving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis
Improving our capacity of identification and reporting on emerging trends New methods and new areas of analysis Monitoring challenges Rapidly changing, globalised drug market Growth of online and virtual
More informationNew drugs in Europe, 2012
ISSN 1977-7841 New drugs in Europe, 2012 EMCDDA Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA 2012 New drugs in Europe, 2012 EMCDDA Europol 2012 Annual Report on the
More informationConflict of Interest Disclosure
Conflict of Interest Disclosure None Street Drugs: What s out there and just how bad is it? Kathy Vo, MD Medical Toxicology Fellow Department of Emergency Medicine California Poison Control System 2 Objectives
More informationSecond international conference on novel psychoactive substances
European Monitoring Centre for Drugs and Drug Addiction programme Second international conference on novel psychoactive substances 12 13 September 2013 Swansea, UK Scientific organisers Professor Andy
More informationIn order to do this we want a consistent approach from Sheffield agencies to maximise the impact of this work.
The Citywide response to Spice use in Sheffield Spice use needs a co-ordinated response. Our vision is that all workers in contact with Spice users will have the opportunity to respond to Spice use in
More informationEuropol EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone)
Europol EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone) In accordance with Article 5 of Council Decision 2005/387/JHA on the information exchange, risk assessment
More informationNovel Psychoactive Substances. Legal Highs. Dr James Dear
Novel Psychoactive Substances Legal Highs Dr James Dear Consultant Toxicologist NPIS Edinburgh What am I going to cover? National Poisons Information Service Novel Psychoactive Substances History, classification,
More informationSubstance briefing: MPA
Substance briefing: MPA This technical folder provides information on MPA. The information provided is based on a number of existing data sources and work undertaken as part of the I-TREND project. Research
More informationCLINICAL ANALYTICS: TOXICOLOGICAL SCREENING/ SCREENING FOR DRUGS OF ABUSE
CLINICAL ANALYTICS: TOXICOLOGICAL SCREENING/ SCREENING FOR DRUGS OF ABUSE Analytical Strategy, Fall Semester 2016 Elija Eggel, Dora Harangozo 1.11.2016 1 Table of Contents What are legal highs? Natural
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-EIGHTH REGULAR SESSION November 11-13, 2015 Trujillo, Perú OEA/Ser.L/XIV.2.58 CICAD/doc.2201/15 27
More informationAuthor: Laura A Scott and Lucy Burns, National Drug and Alcohol Research Centre, University of New South Wales
EDRS april 2011 Author: Laura A Scott and Lucy Burns, National Drug and Alcohol Research Centre, University of New South Wales Suggested citation: Scott, L. A. & Burns, L. (2011). Has ecstasy peaked? A
More informationTHE SYNTHETIC DRUGS. Timothy E. Wilens, MD
THE SYNTHETIC DRUGS Timothy E. Wilens, MD Director, Center for Addiction Medicine Chief, Division of Child and Adolescent Psychiatry, Massachusetts General Hospital Harvard Medical School Disclosures*
More informationUppers, Downers and Legal Highs STREET DRUGS. Ball
Uppers, Downers and Legal Highs STREET DRUGS Objectives Understand the pathophysiology of cocaine intoxication Appreciate differences between cocaine toxicity and MDMA, bath salts, and other synthetic
More informationPrimer on Synthetic Opioids I/S Brian Dempsey
Primer on Synthetic Opioids I/S Brian Dempsey 412-777-6945 brian.w.dempsey@usdoj.gov Sources - ACOME - Overdose Free PA Website - Pennsylvania Opioid Overdose Reduction Technical Assistance Center (TAC)
More informationInformal meeting of the Justice and Home Affairs Ministers Sopot July 2011
Informal meeting of the Justice and Home Affairs Ministers Sopot 18-19 July 2011 New challenges to EU anti-drug policy. I. Introduction Every hour an EU citizen dies of a drug overdose. There are as many
More informationⅠ.TRENDS IN ILLICIT DRUGS SMUGGLING 1. Summary The total number of seizures of illicit drugs *1 was 1,896 (4.9 times year on year) (highest number on
Ⅰ.TRENDS IN ILLICIT DRUGS SMUGGLING 1. Summary The total number of seizures of illicit drugs *1 was 1,896 (4.9 times year on year) (highest number on record). And the seized quantity *2 was approximately
More informationINTER AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY SECOND REGULAR SESSION November 28 30, 2012 San José, Costa Rica OEA/Ser.L/XIV.2.52 CICAD/doc.1980/12
More informationwedinos.org WEDINOS Headlines 5,300 Cathinones 4, Substances BULLETIN Samples received Samples analysed Samples rejected
WEDINOS Quarterly Newsletter Issue 9 Apr - Jun 2016 BULLETIN WEDINOS Headlines Collecting, Testing, Inorming wedinos.org The WEDINOS project has been designed or the collection and testing o substances
More informationAH-7921 RISK ASSESSMENTS 13. About this series
RISK ASSESSMENTS 13 AH-7921 ISSN 1725-4493 Report on the risk assessment of 3,4-dichloro- N-{[1-(dimethylamino)cyclohexyl]methyl} benzamide (AH-7921) in the framework of the Council Decision on new psychoactive
More informationRESIDENTIAL SUBSTANCE ABUSE TREATMENT (RSAT)
RESIDENTIAL SUBSTANCE ABUSE TREATMENT (RSAT) Synthetic Drugs December 19, 2018 Philip Barbour TASC-IL This project was supported by grant No. 2016-MU-BX-K021 awarded by the Bureau of Justice Assistance.
More information5923/07 ZH/mp 1 DG H II A
COUNCIL OF THE EUROPEAN UNION Brussels, 7 February 2007 5923/07 CORDROGUE 13 COVER NOTE from : Europol and EMCDDA to : Horizontal Working Party on Drugs Subject : EMCDDA-Europol 2006 Annual Report on the
More informationReport on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs
EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION Report on the Risk Assessment of 4-MTA in the Framework of the Joint Action on New Synthetic Drugs Report on the Risk Assessment of 4-MTA in the
More informationCzech web shop analysis did not find any web shop advertised branded products as containing MDPBP substance.
Substance briefing: MDPBP This technical folder provides information on MDPBP. The information provided is based on a number of existing data sources and work undertaken as part of the I-TREND project.
More informationTaking Stock of the 2009 PoA Research and Trend Analysis Branch
Taking Stock of the 2009 PoA Research and Trend Analysis Branch Eliminate or reduce significantly and measurably: The five targets Illicit cultivation of opium, coca, cannabis Illicit demand of drugs and
More informationResults from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS)
Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS) Grund, Jean-Paul Vavrinčíková, Lenka Janíková, Barbara Fidesová, Hana Health responses to NPS EMCDDA, Lisboa. 28-10-2015
More informationAppendix 2: The nature and addictiveness of commonly used illicit drugs
Appendix 2: The nature and addictiveness of commonly used illicit drugs Amphetamine A synthetic drug that can easily be produced on a small scale. It can be snorted, swallowed or smoked or, less frequently,
More informationSA 15 REPORT ON THE ANALYZED SUBSTANCES IN SPAIN BY ENERGY CONTROL DURING 2015 A PROGRAM OF THE ASSOCIATION:
SA 15 REPORT ON THE ANALYZED SUBSTANCES IN SPAIN BY ENERGY CONTROL DURING 2015 A PROGRAM OF THE ASSOCIATION: PARTNERS: 3 2 PRESENTATION This report presents the synthetic substances, tested by Energy Control
More informationCommunity Epidemiology Report November 2014
Community Epidemiology Report November 214 Drug Abuse Trends Update Broward County and South Florida James N. Hall, Epidemiologist Center for Applied Research on Substance Use and Health Disparities Nova
More informationThe causes of misuse:
The Drug Misuse The causes of misuse: Availability of drugs. A vulnerable personality. Adverse social environment. Regular drug taking play a role. Determining misuse and dependence, it is unclear whether
More informationMinneapolis/St. Paul, Minnesota Drug Abuse Trends: January 2014 Update
Minneapolis/St. Paul, Minnesota Drug Abuse Trends: January 2014 Update Carol Falkowski Drug Abuse Dialogues ABSTRACT Heroin and other opiate addiction continued to escalate in the Twin Cities in 2013.
More informationCentral Asia Synthetic Drugs Situation Assessment. A Report from the UNODC Global SMART Programme
Central Asia Synthetic Drugs Situation Assessment A Report from the UNODC Global SMART Programme December 2017 CONTENTS PREFACE 3 GENERAL ABBREVIATIONS 4 CHEMICAL ABBREVIATIONS 5 EXPLANATORY NOTES 6 EXECUTIVE
More informationIllicit Drugs GHB. How GHB is Used. GHB Recreational Use. GHB Effects (1) Oral intake. GHB:Gammahydroxybutyrate or Sodium Oxybate
GHB:Gammahydroxybutyrate or Sodium Oxybate Illicit Drugs Wendy Porteous 2014 Fantasy, grievous bodily harm (GBH), liquid ecstasy Laboratory manufactured. Also produced in the brain through synthesis of
More informationWorld Drug Report 2017
World Drug Report 2017 DEMAND Global trends in estimated number of drug users and people with drug user disorders, 2006-2015 Global trends in the estimated prevalence of drug use and prevalence of people
More informationDrug Trend Bulletin Issue 2 July 2015
Issue 2 July 2015 Pink and yellow colour crack cocaine recovered in the Greenock area. Please see attached photos of pink and yellow colour crack cocaine. They are from separate seizures in the Greenock
More informationNew patterns of drug use in Hungary
New patterns of drug use in Hungary Gergely Horváth Hungarian National Focal Point PDU Annual Expert Meeting 2012 Lisbon, 25-26 September 2012 First glance From 2009 on decrease in heroin availability,
More informationGlobal drug trends and sustainable development
Lau Global drug trends and sustainable development Chloé Carpentier Chief, Drug Research Section UNODC Göteborg, 15 November 2017 Global trends in estimated number of drug users and people with drug user
More information1. Background 2. The Big Picture 3. Global trends 4. Regional trends E/SE Asia 5. Effective responses
Simultaneous launches: Vienna and Bangkok 13 Sep 2011 1. Background 2. The Big Picture 3. Global trends 4. Regional trends E/SE Asia 5. Effective responses The international drug control system 1. Based
More informationNEW TRENDS IN USE, CONSEQUENCES / DAMAGES AND MARKETS. 2nd Annual Meeting of National Drug Observatories COPOLAD II Lisbon, November 2017
NEW TRENDS IN USE, CONSEQUENCES / DAMAGES AND MARKETS 2nd Annual Meeting of National Drug Observatories COPOLAD II Lisbon, 13-17 November 217 THE QUESTIONS In the last two years What recent changes and
More informationfactsheet New psychoactive substances (NPS): Who is this factsheet for? What are new psychoactive substances? NPS and the law
New psychoactive substances (NPS): factsheet Who is this factsheet for? This factsheet is aimed at professionals who do not work specifically in the drugs field, but who may encounter substance misuse
More informationSubstance abuse. Barbara Loi, Stefania Chiappini, Hugh Claridge, John Corkery, Carla Gimeno Clemente, Christine Goodair, Fabrizio Schifano
10th International Training Seminar in Child and Adolescent Psychiatry, 23-29 June 2013, Bocca di Magra (La Spezia), Italy Substance abuse Barbara Loi, Stefania Chiappini, Hugh Claridge, John Corkery,
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D SIXTY-FIRST REGULAR SESSION April 24-26, 2017 Washington, D.C. OEA/Ser.L/XIV.2.61 CICAD/doc.2301/17 21 April 2017 Original: Español EARLY WARNING
More informationThe National Methamphetamine Symposium
The National Methamphetamine Symposium Making Research Work in Practice 12 May 2015 Arts Centre, Melbourne Physical and psychological effects of methamphetamine use Amanda Baker PhD National Centre for
More information39 th Expert Committee on Drug Dependence Process and recommendations
39 th Expert Committee on Drug Dependence Process and recommendations Dr Gilles Forte Essential Medicines and Health Products Department WHO role within the International Drug Conventions To recommend
More information